Compagnie Lombard Odier S Cm A Abbott Laboratories Transaction History

Compagnie Lombard Odier S Cm A

$6.12 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$90.19 - $110.4 $4.6 Million - $5.63 Million	50,997 Added 6.52%	833,302 $91.7 Million
Q3 2023 Oct 23, 2023	BUY	$95.53 - $114.62 $74.7 Million - $89.7 Million	782,305 New	782,305 $75.8 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $1.53 Million - $1.8 Million	15,808 Added 1.93%	834,306 $84.5 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $1.79 Million - $2.1 Million	-18,869 Reduced 2.25%	818,498 $89.9 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $7.87 Million - $9.11 Million	81,310 Added 10.75%	837,367 $81 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $4.82 Million - $5.82 Million	47,206 Added 6.66%	756,057 $82.1 Million
Q1 2022 Apr 27, 2022	SELL	$114.02 - $139.04 $2.35 Million - $2.86 Million	-20,589 Reduced 2.82%	708,851 $83.9 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $1.24 Million - $1.51 Million	-10,709 Reduced 1.45%	729,440 $103 Million
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $4.64 Million - $5.13 Million	-39,773 Reduced 5.1%	740,149 $87.4 Million
Q2 2021 Jul 15, 2021	SELL	$105.79 - $124.53 $3.3 Million - $3.88 Million	-31,169 Reduced 3.84%	779,922 $90.4 Million
Q1 2021 Apr 23, 2021	BUY	$108.84 - $128.23 $22 Million - $25.9 Million	201,681 Added 33.09%	811,091 $97.2 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $2.17 Million - $2.37 Million	20,702 Added 3.52%	609,410 $66.7 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $1.01 Million - $1.22 Million	10,975 Added 1.9%	588,708 $64.1 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $11.4 Million - $14.6 Million	148,962 Added 34.74%	577,733 $52.8 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $16 Million - $23.4 Million	254,521 Added 146.07%	428,771 $33.8 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $3.2 Million - $3.56 Million	40,716 Added 30.49%	174,250 $15.1 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $81,840 - $88,740	1,000 Added 0.75%	133,534 $11.2 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $135,994 - $158,610	-1,866 Reduced 1.39%	132,534 $11.1 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $157,802 - $190,782	2,383 Added 1.81%	134,400 $10.7 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $174,455 - $197,632	-2,661 Reduced 1.98%	132,017 $9.55 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $137,369 - $165,720	2,259 Added 1.71%	134,678 $9.88 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $140,413 - $154,974	2,439 Added 1.88%	132,419 $8.08 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $56,270 - $63,620	-1,000 Reduced 0.76%	129,980 $7.79 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $116,861 - $125,112	-2,177 Reduced 1.63%	130,980 $7.48 Million
Q2 2017 Aug 14, 2017	BUY	N/A	133,157	133,157 $6.47 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.5 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.2 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.89 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.62 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.18 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Account